Lucid Diagnostics (LUCD) Cash from Financing Activities (2020 - 2026)
Lucid Diagnostics' (LUCD) quarterly Cash from Financing Activities came in at $5.5 million in Q1 2026, down 64.46% YoY from $15.4 million in Q1 2025, and up 274250.0% on a QoQ basis from $2000.0 in Q4 2025.
Lucid Diagnostics (LUCD) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 7 years of Cash from Financing Activities data on file, last reported at $5.5 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 64.46% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.1 million (up 8.67% YoY) and the FY2025 annual result came in at $59.0 million, up 22.34% from the prior year.
- Cash from Financing Activities grew to $5.5 million in Q1 2026, from $2000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $27.1 million in Q3 2025 to a low of $1000.0 in Q4 2022.
- A 5-year average of $9.1 million and a median of $5.2 million in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities slumped 100.0% — and 2023, when it soared 499900.0%.
- Tracing LUCD's Cash from Financing Activities over 5 years: stood at $1000.0 in 2022, then soared by 499900.0% to $5.0 million in 2023, then jumped by 259.98% to $18.0 million in 2024, then tumbled by 99.99% to $2000.0 in 2025, then soared by 274250.0% to $5.5 million in 2026.
- The last three Cash from Financing Activities figures came in at $5.5 million (Q1 2026), $2000.0 (Q4 2025), and $27.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Lucid Diagnostics | 176.73 Mn | 143.33 Mn | 55,000.00 | 16.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.85 Mn |
| Jun 30, 2026 | 16.85 Mn |
| Mar 31, 2026 | 5.49 Mn |
| Mar 31, 2026 | 5.49 Mn |
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 27.13 Mn |
| Sep 30, 2025 | 27.13 Mn |
| Jun 30, 2025 | 16.46 Mn |
| Jun 30, 2025 | 16.46 Mn |
| Mar 31, 2025 | 15.44 Mn |
| Mar 31, 2025 | 15.44 Mn |
| Dec 31, 2024 | 18.00 Mn |
| Dec 31, 2024 | 18.00 Mn |
| Sep 30, 2024 | 94,000.00 |
| Sep 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 11.63 Mn |
| Jun 30, 2024 | 11.63 Mn |
| Mar 31, 2024 | 18.52 Mn |
| Mar 31, 2024 | 18.52 Mn |